Biblio

Export 335 results:
Author Title [ Type(Asc)] Year
Filters: First Letter Of Last Name is I  [Clear All Filters]
Journal Article
R. S. Doody, Thomas, R. G., Farlow, M., Iwatsubo, T., Vellas, B., Joffe, S., Kieburtz, K., Raman, R., Sun, X., Aisen, P. S., Siemers, E., Liu-Seifert, H., and Mohs, R., “Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease.”, N Engl J Med, vol. 370, no. 4, pp. 311-21, 2014.
M. Okuda, Fujita, Y., Hijikuro, I., Wada, M., Uemura, T., Kobayashi, Y., Waku, T., Tanaka, N., Nishimoto, T., Izumi, Y., Kume, T., Akaike, A., Takahashi, T., and Sugimoto, H., “PE859, A Novel Curcumin Derivative, Inhibits Amyloid-β and Tau Aggregation, and Ameliorates Cognitive Dysfunction in Senescence-Accelerated Mouse Prone 8.”, J Alzheimers Dis, vol. 59, no. 1, pp. 313-328, 2017.
B. Hanseeuw, Dricot, L., Lhommel, R., Quenon, L., and Ivanoiu, A., “Patients with Amyloid-Negative Mild Cognitive Impairment have Cortical Hypometabolism but the Hippocampus is Preserved.”, J Alzheimers Dis, vol. 53, no. 2, pp. 651-60, 2016.
J. J. Iliff, Wang, M., Liao, Y., Plogg, B. A., Peng, W., Gundersen, G. A., Benveniste, H., G Vates, E., Deane, R., Goldman, S. A., Nagelhus, E. A., and Nedergaard, M., “A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β.”, Sci Transl Med, vol. 4, no. 147, p. 147ra111, 2012.
M. Wezyk, Szybinska, A., Wojsiat, J., Szczerba, M., Day, K., Ronnholm, H., Kele, M., Berdynski, M., Peplonska, B., Fichna, J. Piotr, Ilkowski, J., Styczyńska, M., Barczak, A., Zboch, M., Filipek-Gliszczyńska, A., Bojakowski, K., Skrzypczak, M., Ginalski, K., Kabza, M., Makalowska, I., Barcikowska-Kotowicz, M., Wojda, U., Falk, A., and Zekanowski, C., “Overactive BRCA1 Affects Presenilin 1 in Induced Pluripotent Stem Cell-Derived Neurons in Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 1, pp. 175-202, 2018.
J. Antonio Allué, Sarasa, L., Izco, M., Pérez-Grijalba, V., Fandos, N., Pascual-Lucas, M., Ogueta, S., Pesini, P., and Sarasa, M., “Outstanding Phenotypic Differences in the Profile of Amyloid-β between Tg2576 and APPswe/PS1dE9 Transgenic Mouse Models of Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 3, pp. 773-85, 2016.
C. R. Jack, Knopman, D. S., Weigand, S. D., Wiste, H. J., Vemuri, P., Lowe, V., Kantarci, K., Gunter, J. L., Senjem, M. L., Ivnik, R. J., Roberts, R. O., Rocca, W. A., Boeve, B. F., and Petersen, R. C., “An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease.”, Ann Neurol, vol. 71, no. 6, pp. 765-75, 2012.
A. M. Racine, Touroutoglou, A., Abrantes, T., Wong, B., Fong, T. G., Cavallari, M., Travison, T. G., Gou, Y., Marcantonio, E. R., Alsop, D. C., Jones, R. N., Inouye, S. K., and Dickerson, B. C., “Older Patients with Alzheimer's Disease-Related Cortical Atrophy Who Develop Post-Operative Delirium May Be at Increased Risk of Long-Term Cognitive Decline After Surgery.”, J Alzheimers Dis, vol. 75, no. 1, pp. 187-199, 2020.
A. Tom Kodamullil, Iyappan, A., Karki, R., Madan, S., Younesi, E., and Hofmann-Apitius, M., “Of Mice and Men: Comparative Analysis of Neuro-Inflammatory Mechanisms in Human and Mouse Using Cause-and-Effect Models.”, J Alzheimers Dis, vol. 59, no. 3, pp. 1045-1055, 2017.
M. Tombini, Sicari, M., Pellegrino, G., Ursini, F., Insardá, P., and Di Lazzaro, V., “Nutritional Status of Patients with Alzheimer's Disease and Their Caregivers.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1619-1627, 2016.
B. O. A. Botchway, Moore, M. K., Akinleye, F. O., Iyer, I. C., and Fang, M., “Nutrition: Review on the Possible Treatment for Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 3, pp. 867-883, 2018.
E. N. Wilson, Carmo, S. Do, Welikovitch, L. A., Hall, H., Aguilar, L. Flores, Foret, M. K., M Iulita, F., Jia, D. Tong, Marks, A. R., Allard, S., Emmerson, J. T., Ducatenzeiler, A., and A Cuello, C., “NP03, a Microdose Lithium Formulation, Blunts Early Amyloid Post-Plaque Neuropathology in McGill-R-Thy1-APP Alzheimer-Like Transgenic Rats.”, J Alzheimers Dis, vol. 73, no. 2, pp. 723-739, 2019.
N. Baazaoui and Iqbal, K., “A Novel Therapeutic Approach to Treat Alzheimer's Disease by Neurotrophic Support During the Period of Synaptic Compensation.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1211-1218, 2018.
I. Piaceri, Imperiale, D., Ghidoni, E., Atzori, C., Bagnoli, S., Ferrari, C., Ungari, S., Ambrogio, L., Sorbi, S., and Nacmias, B., “Novel GRN Mutations in Alzheimer's Disease and Frontotemporal Lobar Degeneration.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1683-1689, 2018.
S. Nakamura, Yomota, S., Ito, H., Akinaga, N., Hori, A., Chinomi, K., Suzuki, H., Uchida, K., and Asada, T., “A Novel Cognitive Function Scale Using Functional Near-Infrared Spectroscopy for Evaluating Cognitive Dysfunction.”, J Alzheimers Dis, vol. 81, no. 4, pp. 1579-1588, 2021.
K. Abe, Shang, J., Shi, X., Yamashita, T., Hishikawa, N., Takemoto, M., Morihara, R., Nakano, Y., Ohta, Y., Deguchi, K., Ikeda, M., Ikeda, Y., Okamoto, K., Shoji, M., Takatama, M., Kojo, M., Kuroda, T., Ono, K., Kimura, N., Matsubara, E., Osakada, Y., Wakutani, Y., Takao, Y., Higashi, Y., Asada, K., Senga, T., Lee, L. - J., and Tanaka, K., “A New Serum Biomarker Set to Detect Mild Cognitive Impairment and Alzheimer's Disease by Peptidome Technology.”, J Alzheimers Dis, vol. 73, no. 1, pp. 217-227, 2020.
K. Abe, Shang, J., Shi, X., Yamashita, T., Hishikawa, N., Takemoto, M., Morihara, R., Nakano, Y., Ohta, Y., Deguchi, K., Ikeda, M., Ikeda, Y., Okamoto, K., Shoji, M., Takatama, M., Kojo, M., Kuroda, T., Ono, K., Kimura, N., Matsubara, E., Osakada, Y., Wakutani, Y., Takao, Y., Higashi, Y., Asada, K., Senga, T., Lee, L. - J., and Tanaka, K., “A New Serum Biomarker Set to Detect Mild Cognitive Impairment and Alzheimer's Disease by Peptidome Technology.”, J Alzheimers Dis, vol. 73, no. 1, pp. 217-227, 2020.
P. Cisternas, Zolezzi, J. M., Lindsay, C., Rivera, D. S., Martinez, A., Bozinovic, F., and Inestrosa, N. C., “New Insights into the Spontaneous Human Alzheimer's Disease-Like Model Octodon degus: Unraveling Amyloid-β Peptide Aggregation and Age-Related Amyloid Pathology.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1145-1163, 2018.
R. Resende, Ferreira-Marques, M., Moreira, P., Coimbra, J. R. M., Baptista, S. J., Isidoro, C., Salvador, J. A. R., Dinis, T. C. P., Pereira, C. F., and Santos, A. E., “New BACE1 Chimeric Peptide Inhibitors Selectively Prevent AβPPβ Cleavage Decreasing Amyloid-β Production and Accumulation in Alzheimer's Disease Models.”, J Alzheimers Dis, vol. 76, no. 4, pp. 1317-1337, 2020.
W. Wei, Liu, Y., Dai, C., Baazaoui, N., Tung, Y. - C., Liu, F., and Iqbal, K., “Neurotrophic Treatment Initiated During Early Postnatal Development Prevents the Alzheimer-Like Behavior and Synaptic Dysfunction.”, J Alzheimers Dis, vol. 82, no. 2, pp. 631-646, 2021.
Y. Ueda, Satoh, M., Tabei, K. - I., Kida, H., Ii, Y., Asahi, M., Maeda, M., Sakuma, H., and Tomimoto, H., “Neuropsychological Features of Microbleeds and Cortical Microinfarct Detected by High Resolution Magnetic Resonance Imaging.”, J Alzheimers Dis, vol. 53, no. 1, pp. 315-25, 2016.
M. E. Mortby, Burns, R., Eramudugolla, R., Ismail, Z., and Anstey, K. J., “Neuropsychiatric Symptoms and Cognitive Impairment: Understanding the Importance of Co-Morbid Symptoms.”, J Alzheimers Dis, vol. 59, no. 1, pp. 141-153, 2017.
J. M. Zolezzi, Lindsay, C. B., Serrano, F. G., Ureta, R. C., Theoduloz, C., Schmeda-Hirschmann, G., and Inestrosa, N. C., “Neuroprotective Effects of Ferruginol, Jatrophone, and Junicedric Acid Against Amyloid-β Injury in Hippocampal Neurons.”, J Alzheimers Dis, vol. 63, no. 2, pp. 705-723, 2018.
S. P. Raikwar, Thangavel, R., Dubova, I., Ahmed, M. Ejaz, Selvakumar, P. Govindhasa, Kempuraj, D., Zaheer, S., Iyer, S., and Zaheer, A., “Neuro-Immuno-Gene- and Genome-Editing-Therapy for Alzheimer's Disease: Are We There Yet?”, J Alzheimers Dis, vol. 65, no. 2, pp. 321-344, 2018.
A. Iyappan, Younesi, E., Redolfi, A., Vrooman, H., Khanna, S., Frisoni, G. B., and Hofmann-Apitius, M., “Neuroimaging Feature Terminology: A Controlled Terminology for the Annotation of Brain Imaging Features.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1153-1169, 2017.

Pages